Report Detail
Global Radiopharmaceuticals Market Growth 2019-2024
- RnM2872431 |
- 04 February, 2019 |
- Global |
- 158 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The proportion of Diagnostic Radioisotopes in 2016 is about 89.22%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 62.63%.
According to this study, over the next five years the Radiopharmaceuticals market will register a 7.8% CAGR in terms of revenue, the global market size will reach US$ 7130 million by 2024, from US$ 4900 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Radiopharmaceuticals business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
This study considers the Radiopharmaceuticals value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Radiopharmaceuticals consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Radiopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Radiopharmaceuticals Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Radiopharmaceuticals Consumption 2014-2024
- 2.1.2 Radiopharmaceuticals Consumption CAGR by Region
- 2.2 Radiopharmaceuticals Segment by Type
- 2.2.1 Diagnostic Radioisotopes
- 2.2.2 Therapeutic Radioisotopes
- 2.3 Radiopharmaceuticals Consumption by Type
- 2.3.1 Global Radiopharmaceuticals Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Radiopharmaceuticals Sale Price by Type (2014-2019)
- 2.4 Radiopharmaceuticals Segment by Application
- 2.4.1 Oncology
- 2.4.2 Cardiology
- 2.4.3 Other
- 2.5 Radiopharmaceuticals Consumption by Application
- 2.5.1 Global Radiopharmaceuticals Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Radiopharmaceuticals Value and Market Share by Application (2014-2019)
- 2.5.3 Global Radiopharmaceuticals Sale Price by Application (2014-2019)
3 Global Radiopharmaceuticals by Players
- 3.1 Global Radiopharmaceuticals Sales Market Share by Players
- 3.1.1 Global Radiopharmaceuticals Sales by Players (2017-2019)
- 3.1.2 Global Radiopharmaceuticals Sales Market Share by Players (2017-2019)
- 3.2 Global Radiopharmaceuticals Revenue Market Share by Players
- 3.2.1 Global Radiopharmaceuticals Revenue by Players (2017-2019)
- 3.2.2 Global Radiopharmaceuticals Revenue Market Share by Players (2017-2019)
- 3.3 Global Radiopharmaceuticals Sale Price by Players
- 3.4 Global Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Radiopharmaceuticals Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Radiopharmaceuticals by Regions
- 4.1 Radiopharmaceuticals by Regions
- 4.1.1 Global Radiopharmaceuticals Consumption by Regions
- 4.1.2 Global Radiopharmaceuticals Value by Regions
- 4.2 Americas Radiopharmaceuticals Consumption Growth
- 4.3 APAC Radiopharmaceuticals Consumption Growth
- 4.4 Europe Radiopharmaceuticals Consumption Growth
- 4.5 Middle East & Africa Radiopharmaceuticals Consumption Growth
5 Americas
- 5.1 Americas Radiopharmaceuticals Consumption by Countries
- 5.1.1 Americas Radiopharmaceuticals Consumption by Countries (2014-2019)
- 5.1.2 Americas Radiopharmaceuticals Value by Countries (2014-2019)
- 5.2 Americas Radiopharmaceuticals Consumption by Type
- 5.3 Americas Radiopharmaceuticals Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Radiopharmaceuticals Consumption by Countries
- 6.1.1 APAC Radiopharmaceuticals Consumption by Countries (2014-2019)
- 6.1.2 APAC Radiopharmaceuticals Value by Countries (2014-2019)
- 6.2 APAC Radiopharmaceuticals Consumption by Type
- 6.3 APAC Radiopharmaceuticals Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Radiopharmaceuticals by Countries
- 7.1.1 Europe Radiopharmaceuticals Consumption by Countries (2014-2019)
- 7.1.2 Europe Radiopharmaceuticals Value by Countries (2014-2019)
- 7.2 Europe Radiopharmaceuticals Consumption by Type
- 7.3 Europe Radiopharmaceuticals Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Radiopharmaceuticals by Countries
- 8.1.1 Middle East & Africa Radiopharmaceuticals Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Radiopharmaceuticals Value by Countries (2014-2019)
- 8.2 Middle East & Africa Radiopharmaceuticals Consumption by Type
- 8.3 Middle East & Africa Radiopharmaceuticals Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Radiopharmaceuticals Distributors
- 10.3 Radiopharmaceuticals Customer
11 Global Radiopharmaceuticals Market Forecast
- 11.1 Global Radiopharmaceuticals Consumption Forecast (2019-2024)
- 11.2 Global Radiopharmaceuticals Forecast by Regions
- 11.2.1 Global Radiopharmaceuticals Forecast by Regions (2019-2024)
- 11.2.2 Global Radiopharmaceuticals Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Radiopharmaceuticals Forecast by Type
- 11.8 Global Radiopharmaceuticals Forecast by Application
12 Key Players Analysis
- 12.1 Bracco Imaging
- 12.1.1 Company Details
- 12.1.2 Radiopharmaceuticals Product Offered
- 12.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Bracco Imaging News
- 12.2 Bayer
- 12.2.1 Company Details
- 12.2.2 Radiopharmaceuticals Product Offered
- 12.2.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Bayer News
- 12.3 Mallinckrodt
- 12.3.1 Company Details
- 12.3.2 Radiopharmaceuticals Product Offered
- 12.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Mallinckrodt News
- 12.4 Nordion
- 12.4.1 Company Details
- 12.4.2 Radiopharmaceuticals Product Offered
- 12.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Nordion News
- 12.5 Triad Isotopes
- 12.5.1 Company Details
- 12.5.2 Radiopharmaceuticals Product Offered
- 12.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Triad Isotopes News
- 12.6 Lantheus
- 12.6.1 Company Details
- 12.6.2 Radiopharmaceuticals Product Offered
- 12.6.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Lantheus News
- 12.7 IBA Group
- 12.7.1 Company Details
- 12.7.2 Radiopharmaceuticals Product Offered
- 12.7.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 IBA Group News
- 12.8 GE Healthcare
- 12.8.1 Company Details
- 12.8.2 Radiopharmaceuticals Product Offered
- 12.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 GE Healthcare News
- 12.9 China Isotope & Radiation
- 12.9.1 Company Details
- 12.9.2 Radiopharmaceuticals Product Offered
- 12.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 China Isotope & Radiation News
- 12.10 Jubilant Pharma
- 12.10.1 Company Details
- 12.10.2 Radiopharmaceuticals Product Offered
- 12.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Jubilant Pharma News
- 12.11 Eli Lilly
- 12.12 Advanced Accelerator Applications
- 12.13 SIEMENS
- 12.14 Dongcheng
- 12.15 Navidea
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Radiopharmaceuticals . Industry analysis & Market Report on Radiopharmaceuticals is a syndicated market report, published as Global Radiopharmaceuticals Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Radiopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
